Biotech · Private company · New York, NY, US

Chimerna Therapeutics Inc.

Track this companyFree. Adds Chimerna Therapeutics Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards3

Synthetic biology approaches for bio-orthogonal labeling of circular RNAsFiscal year 2025 · $302.6KNIH RePORTER 1R43GM157885-01 · fetched Nov 12, 2026
Development of circRNA manufacturing platform in yeastFiscal year 2024 · $297.6KNIH RePORTER 1R43TR004890-01 · fetched Nov 12, 2026
Next-generation RNA synthesis and labeling kitsFiscal year 2024 · $311.1KNIH RePORTER 5R44GM139433-04 · fetched Nov 12, 2026